• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10310
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiopulmonary Arrest (1765); Death (1802)
Event Date 10/18/2018
Event Type  Death  
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The run data file (rdf) was analyzed for this event.Signals in the rdf indicated that the spectra optia system operated as intended.Per the physician's statement, the cause of death was cardiopulmonary arrest due to shock,leading to multiorgan disfunction, with cml leukostasis, confirming the death of the patient was unrelated to the procedure.A terumo bct service technician visited the customer's site and performed a machine checkout.Upon inspection, there were no concerns noted.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer contacted a terumo bct clinical specialist for assistance in calculating a white blood cell depletion (wbcd) using continuous mononuclear cell (cmnc) collection.Per the customer, they wanted to perform a white blood cell depletion (wbcd) on the patient, however, the machine being used did not have the wbcd protocol, so they used the cmnc protocol instead.The customer was called back to see how the procedure went and the customer informed terumo bct that the cmnc procedure lasted 198 minutes and the patient died several hours after the procedure.The customer stated that they could not release the autopsy results.The spectra optia exchange set is not available for return because it was discarded by the customer.The customer declined to provide the patient identifier.This report is being filed due to patient death, although per current information there is no suspected malfunction with the terumo bct device or allegation of a malfunction.
 
Manufacturer Narrative
This report is being filed to provide additional information.Investigation: the customer initially contacted terumo bct support specialist to calculate the collect flowrate (cfr) for a white blood cell depletion (wbcd) procedure using a continuous mononuclearcell (cmnc) collection protocol.The customer was advised to lower the inlet flow rate to 34 or 35 and the cfr calculated to 9.7 and 10.The reason not to increase the inlet flow rate was also explained to the customer.The customer further informed that they were not able to confirm the run screen as the total blood volume (tbv) entered was twice the amount.The support specialist suggested to lower the tbv to 1.2 and received confirmation of the runscreen.The customer stated they will discuss the processed replacement fluid and the tbv with the physician.During customer follow-up on 10/19/18, the customer stated that the patient had expired.The rdf was analyzed for this event.The signals in the rdf indicated that total 8 alarms were experienced.The operator was able to continue through the alarms and completed the procedure.The procedure was performed smoothly.The machine performed per the specifications and designs and completed the procedure while simultaneously keeping the patientsafe.Per terumo bct medical safety review, the device did not cause or contribute to this event.Root cause: per the physician's statement and the additional information provided by the customer, the rdf, dhr review, and the service call, the optia device is not the cause of the patient death.In addition, the customer also stated that the death was not due to a malfunction of the system.The physician determined that the patient's death was a result of the underlying disease, cml with complications of cardiopulmonary arrest due to shock leading to multiorgan dysfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w collins ave
lakewood, CO 80215
3032392246
MDR Report Key8055597
MDR Text Key126722735
Report Number1722028-2018-00301
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583103108
UDI-Public05020583103108
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K172590
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 11/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/01/2020
Device Catalogue Number10310
Device Lot Number1809053130
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received11/14/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/05/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00048 YR
Patient Weight78
-
-